Successful commercialization is no longer just about gaining regulatory approval. It is about meeting the needs of a growing number of stakeholders, including physicians, patients, governments and payers. Success requires integrated pharmaceutical teamwork, including the right Medical Communications expertise where needed, to address the traditional silos of R&D, marketing and regulatory and focus on the same goals. This multi-stakeholder approach will ensure your drug gets the best possible chance to succeed in the all-important launch window – and beyond.
PAREXEL Medical Communications translates healthcare discoveries and complex scientific data into motivating communications. As a result, we help sponsors achieve launch excellence and accelerate product adoption and recommendation by healthcare professionals. We also help convey the health-economic benefits of healthcare discoveries to payers, and assist sponsors to optimize market access and reimbursement for their products.
Our world-class team includes scientific strategists and medical writers, clinicians, market access consultants, together with creative and production teams, social media experts and medical event specialists. Such integrated data dissemination expertise helps support accurate, compelling positioning for your product and appropriate advocacy development. It also ensures that data are conveyed to all target audiences in a professional and compliant manner.
With over 400 experts providing world-class medical communication expertise, our global teams are uniquely equipped to help sponsors achieve launch excellence and long-term brand success.
T. +44 1903 288 225
We are a leading global bio/pharmaceutical services organization that helps clients expedite time-to-market through our development and launch services. These include a broad range of clinical development capabilities, integrated advanced technologies, regulatory affairs consulting, and commercialization services.